Insider Trading activities at Immunocellular Therapeutics, Ltd. (IMUC)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunocellular Therapeutics, Ltd. (IMUC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immunocellular Therapeutics, Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 822411.

Total stock buying since 2014: $76,149.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $6,750.


4 insiders reported insider trading activities at Immunocellular Therapeutics, Ltd. (IMUC):
Insider trading activities of Fractor David
Insider trading activities of Gengos Andrew
Insider trading activities of Gringeri Anthony
Insider trading activities of Yu John S

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Immunocellular Therapeutics, Ltd. (IMUC).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2015 98,000 $57,149 0 $0 25,000 $6,750
2014 21,000 $19,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Immunocellular Therapeutics, Ltd. (IMUC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-11 10,000 $4,350 0 $0 0 $0
2015-09 0 $0 0 $0 25,000 $6,750
2015-02 88,000 $52,799 0 $0 0 $0
2014-08 21,000 $19,000 0 $0 0 $0

Table 3. Detailed insider trading at Immunocellular Therapeutics, Ltd. (IMUC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-11-30 Gengos Andrew (President and CEO) Buy 10,000 .43 4,350
2015-09-28 Yu John S (Director) Option Ex 25,000 .27 6,750
2015-02-18 Gringeri Anthony (Senior VP Strategic Resources) Buy 30,000 .60 18,000
2015-02-18 Gengos Andrew (President and CEO) Buy 41,333 .60 24,799
2015-02-18 Fractor David (VP of Finance) Buy 16,667 .60 10,000
2014-08-21 Gringeri Anthony (Senior VP Strategic Resources) Buy 11,000 .91 10,010
2014-08-14 Gengos Andrew (President and CEO) Buy 10,000 .90 8,990

Insider trading activities including stock purchases, stock sales, and option exercises of IMUC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immunocellular Therapeutics, Ltd. (symbol IMUC, CIK number 822411) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.